ZOMETA RTU 4MG INJECTION

Zometa RTU 4mg injection contains the active ingredient Zoledronic Acid. It is part of the family of compounds known as bisphosphonates. It’s used to decrease the amount of calcium present in the blood of adult patients when it is too high because of the presence of tumours. Tumors may accelerate average bone growth to the point where the calcium release from the bone increases. This is called tumour-induced hypercalcemia (TIH). It can also be used to reduce bone problems in adults with bone metastases due to cancerous solid tumours (spread by cancer cells from their site of origin into the bones) as well as the standard cancer treatment.
Zometa RTU 4mg can also be used to treat or prevent osteoporosis (a condition where bones weaken and thin and can break easily) for women who have experienced menopausal change. It can also be employed to combat osteoporosis in males. It’s also utilized to treat Paget’s Disease of the bone (a condition where bones are weak and brittle and are susceptible to deformation and pain or fracture). Other applications include preventing or treating osteoporosis in women and men taking glucocorticoids (a corticosteroid medicine that can result in osteoporosis).
Don’t take this medicine if you’re sensitive to zoledronic acid or any other bisphosphonate or any other ingredient in this medication and the case of pregnancy or nursing. Before beginning treatment, tell your doctor whether you suffer from liver or kidney problems, bone conditions, swelling, pain or a numb jaw. The medicine is not suitable for use by adolescents or youngsters under the age of 18 years old. Zometa RTU 4 mg is not a chemotherapy for cancer and won’t slow down or slow the growth of cancer. However, it is used to treat bone disorders in cancer patients.